ISPOR/ISPE Summit on Real-World Evidence in Health Care Decision Making, October 20, 2017, Washington, DC.
ISPOR and ISPE have collaborated on a joint task force to produce coordinated papers that make specific recommendations for improving the transparency and reproducibility of real-world evidence for use in health care decision making-especially those decisions at the regulatory and payer levels. This 1-day Summit will provide a forum for reviewing these task force reports, considering the perspectives of key stakeholders, and discussing future steps that could help enable these recommendations. click here for more information.
The ISPE call for manuscripts is open! Click here for more information and how to submit a manuscript. The deadline is September 27, 2017.
The European Medicines Agency is assessing how its communications to the general public are perceived and valued. The survey focuses on EMA communication activities to the general public (i.e. EMA information made public mainly through the EMA website such as press releases and news announcements). It does not relate to communication as part of one's regular or professional interaction with EMA (e.g. communications with EMA officials in the context of an evaluation procedure or any other information exchange under working arrangements). Click here to particiate in the survey. Deadline: May 31.
ICPE 2017 Update. Notifications were emailed today to all who submitted abstracts for oral/poster presentations.
Call for Abstracts - Deadline June 16, 2017. Make your plans to attend ISPE's 10th Asian Conference on Pharmacoepidemiology (ACPE) will be held October 29-31 in Brisbane, Australia. Click here for more information. Abstract deadline - June 16, 2017.
The 33rd ICPE call for abstracts is closed. Information on your abstract's status will be available in May 2017.
ISPE is pleased to announce that the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) will take place in Montreal, Canada from Saturday, August 26 - Wednesday, August 30, 2017 at the Palais de Congres de Montreal.